DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Grothey A, Jordan K, Kellner O. et al.
Randomized phase II trial of capecitabine plus irinotecan (CapIri) vs capecitabine plus oxaliplatin (CaPox) as first line therapy of advanced colorectal cancer (ACRC).
Proc Am Soc Clin Oncol 2003; 23: 255-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.